Regeneron Announces Change in Date for Presentation at Barclays Capital 2012 Global Healthcare Conference

TARRYTOWN, N.Y.,March 9, 2012/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) will webcast its presentation at Barclays Capital 2012 Global Healthcare Conference onTuesday, March 13, 2012at3:45 p.m. Eastern Time. TheMarch 13, 2012date is a change from the previously announced date ofMarch 14, 2012and is due to conference rescheduling.

The session may be accessed through the Company's web site,www.regeneron.com, on the Events and Presentations page.  An archived version of the presentation will be available for thirty days after the live webcast.

Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets two products inthe United States, one for the treatment of neovascular (wet) age-related macular degeneration and another for the treatment of a rare inflammatory condition.  Additionally, Regeneron has three regulatory applications pending before the U.S. Food and Drug Administration (FDA) and 10 drug candidates in clinical development. More information and recent news releases are available on the Regeneron web site atwww.regeneron.com.